Pump removal in infected patients with hepatic chemotherapy pumps: When is it necessary?

American Surgeon

Volumn 72, Issue 10, 2006, Pages 880-884

  Roybal, Jonathan J ^a   Feliberti, Eric C ^a   Rouse, Layla ^a   Wagman, Lawrence D ^a,b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLOXURIDINE; ANTINEOPLASTIC ANTIMETABOLITE;

ABDOMINAL ABSCESS; ABDOMINAL INFECTION; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER CHEMOTHERAPY; COLORECTAL CANCER; CONTINUOUS INFUSION; DEMOGRAPHY; DEVICE REMOVAL; FEMALE; HUMAN; INFECTIOUS COMPLICATION; INFUSION PUMP; LIVER ABSCESS; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; PERIOPERATIVE COMPLICATION; SKIN INFECTION; WOUND INFECTION; AGED; COLON TUMOR; COMPARATIVE STUDY; HEPATIC ARTERY; INFECTION; LENGTH OF STAY; LIVER TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; PORTAL VEIN; POSTOPERATIVE COMPLICATION; RECTUM TUMOR; RETROSPECTIVE STUDY; SURGICAL INFECTION; TIME;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; COLONIC NEOPLASMS; DEVICE REMOVAL; FEMALE; FLOXURIDINE; HEPATIC ARTERY; HUMANS; INFUSION PUMPS, IMPLANTABLE; LENGTH OF STAY; LIVER ABSCESS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; PROSTHESIS-RELATED INFECTIONS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; TIME FACTORS;

EID: 33750693944     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kemeny M. Hepatic artery infusion of chemotherapy as a treatment for hepatic metastases from colorectal cancer. Cancer J 2002;8(Suppl 1):S82-8.
2. Hodgson WJ, Friedland M, Ahmed T, et al. Treatment of colorectal hepatic metastases by intrahepatic chemotherapy alone or as an adjuvant to complete or partial removal of metastatic disease. Ann Surg 1986;203:420-5.
3. Sterchi JM, Richards F, White DR, et al. Chemoinfusion of the hepatic artery for metastases to the liver. Surg Gynecol Obstet 1989;168:291-5.
4. Kumada T, Sone Y, Toyoda H, et al. Hepatic arterial infusion chemotherapy for colorectal liver metastases. Gan To Kagaku Ryoho 2004;31:700-5.
5. Sullivan RD, Zurac WZ. Chemotherapy for liver cancer by protracted ambulatory infusion. J Am Med Assoc 1965;194:93-8.
6. Hohn DC, Stagg RJ, Friedman MA, et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol 1989;7:1646-54.
7. Chang AE, Schneider PD, Sugarbaker PH, et al. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987;206:685-93.
8. Faynsod M, Wagman LD, Longmate J, et al. Improved hepatic toxicity profile of portal vein adjuvant hepatic infusional chemotherapy. J Clin Oncol 2005;23:4876-80.
9. Ensminger WD, Gyves JW. Clinical pharmacology of hepatic arterial chemotherapy. Semin Oncol 1983;10:176-82.
10. Sigurdson ER, Ridge JA, Kemeny N, et al. Tumor and liver drug uptake following hepatic artery and portal vein infusion. J Clin Oncol 1987;5:1836-40.
11. Martin JK Jr, O'Connell MJ, Wieand HS, et al. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer: a randomized trial. Arch Surg 1990;125:1022-7.
12. Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 1992;10:1112-8.
13. Haley RW, Culver DH, Morgan WM, et al. Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol 1985;121:206-15.
14. Allen PJ, Nissan A, Picon AI, et al. Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. J Am Coll Surg 2005;201:57-65.
15. Heslin MJ, Medina-Franco H, Parker M, et al. Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival. Arch Surg 2001;136:318-23.